Please enable JavaScript to continue using this application.

Compare $IPSC vs $SABS | Chartloom

Compare

$IPSC vs $SABS

Century Therapeutics Inc · SAB Biotherapeutics Inc

IPSC

Century Therapeutics Inc

SABS

SAB Biotherapeutics Inc

Compare $IPSC vs $SABS

Comparing Century Therapeutics Inc and SAB Biotherapeutics Inc

IPSCCentury Therapeutics Inc

SABSSAB Biotherapeutics Inc

IPSCCentury Therapeutics Inc

Market cap

$265M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

47.8%

52W performance

151.9%

FCF yield

-33.3%

SABSSAB Biotherapeutics Inc

Market cap

$228M

P/E (TTM)

20.43x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

27.4%

FCF yield

-25.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IPSC

SABS

Detailed metrics comparison

IPSC

Century Therapeutics Inc

SABS

SAB Biotherapeutics Inc

Market Cap

IPSC$265M

SABS$228M

Enterprise Value

IPSC$215M

SABS$223M

Price

IPSC$1.47

SABS$2.98

P/E Ratio

IPSCN/A

SABS20.43x

P/S Ratio

IPSC2.41x

SABS204.97x

EV/Sales

IPSC1.98x

SABS201.14x

EV/EBITDA

IPSC0.00x

SABS0.00x

P/B Ratio

IPSC1.19x

SABS1.26x

P/FCF Ratio

IPSCN/A

SABSN/A

EV/FCF

IPSC-2.44x

SABS-3.88x

PEG Ratio

IPSCN/A

SABSN/A

Forward P/E (NTM)

IPSCN/A

SABSN/A

Forward P/S (NTM)

IPSCN/A

SABSN/A

Revenue (TTM)

IPSC$0

SABS$0

Revenue Growth (YoY)

IPSC-100.0%

SABSN/A

Forward Rev Growth

IPSC385.7%

SABS13369.8%

Gross Margin (TTM)

IPSC0.0%

SABS0.0%

Operating Margin (TTM)

IPSC0.0%

SABS0.0%

EBITDA Margin (TTM)

IPSC0.0%

SABS0.0%

Net Margin (TTM)

IPSC0.0%

SABS0.0%

FCF Margin (TTM)

IPSCN/A

SABSN/A

Net Income (TTM)

IPSC$-110M

SABS$2M

FCF (TTM)

IPSC$-88M

SABS$-57M

EPS (TTM)

IPSC-$0.53

SABS$0.00

ROE (TTM)

IPSC-5276.0%

SABS15.2%

ROA (TTM)

IPSC-4059.0%

SABS12.5%

ROIC (TTM)

IPSC-5276.0%

SABS14.6%

Cash

IPSC$50M

SABS$8M

Debt

IPSC$0

SABS$3M

Net Cash/Debt

IPSC$50M

SABS$5M

Current Ratio (TTM)

IPSC8.28x

SABS9.22x

Quick Ratio (TTM)

IPSC7.94x

SABS8.93x

Debt/Equity (TTM)

IPSC0.00x

SABS0.01x

Debt/Assets (TTM)

IPSC0.0%

SABS0.0%

Interest Coverage (TTM)

IPSCN/A

SABSN/A

Net Debt/EBITDA (TTM)

IPSC0.00x

SABS0.00x

Beta

IPSC1.74

SABS0.80

52W Performance

IPSC151.9%

SABS27.4%

YTD Performance

IPSC47.8%

SABS-21.0%

% from 52W High

IPSC-51.6%

SABS-42.1%

% from 52W Low

IPSC237.9%

SABS41.9%

Asset Turnover (TTM)

IPSC0.31x

SABS0.02x

FCF Yield (TTM)

IPSC-33.3%

SABS-25.2%

Earnings Yield (TTM)

IPSC-41.4%

SABS1.1%

Dividend Yield (TTM)

IPSCN/A

SABSN/A

Rule of 40

IPSC-100.0

SABS0.0

EV/GP/RG

IPSCN/A

SABSN/A

Ticker research

View IPSC research View SABS research

Metric	IPSC Century Therapeutics Inc	SABS SAB Biotherapeutics Inc
Market & Valuation
Market Cap	$265M	$228M
Enterprise Value	$215M	$223M
Price	$1.47	$2.98
P/E Ratio	N/A	20.43x
P/S Ratio	2.41x	204.97x
EV/Sales	1.98x	201.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	385.7%	13369.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-110M	$2M
FCF (TTM)	$-88M	$-57M
EPS (TTM)	-$0.53	$0.00
ROE (TTM)	-5276.0%	15.2%
ROA (TTM)	-4059.0%	12.5%
ROIC (TTM)	-5276.0%	14.6%
Financial Health
Cash	$50M	$8M
Debt	$0	$3M
Net Cash/Debt	$50M	$5M
Current Ratio (TTM)	8.28x	9.22x
Quick Ratio (TTM)	7.94x	8.93x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	0.80
52W Performance	151.9%	27.4%
YTD Performance	47.8%	-21.0%
% from 52W High	-51.6%	-42.1%
% from 52W Low	237.9%	41.9%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.02x
FCF Yield (TTM)	-33.3%	-25.2%
Earnings Yield (TTM)	-41.4%	1.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View SABS research

Valuation

P/E Ratio

SABS

20.43x

P/S Ratio

IPSC

2.41x

SABS

204.97x

EV/FCF

SABS

-3.88x

IPSC

-2.44x

Growth & revenue

Revenue Growth TTM

IPSC

-100.0%

Forward Revenue Growth

SABS

13369.8%

IPSC

385.7%

Profitability & performance

Gross Margin

IPSC

0.0%

SABS

0.0%

ROE

SABS

15.2%

IPSC

-5276.0%

FCF Yield %

SABS

-25.2%

IPSC

-33.3%

52-Week Performance

IPSC

151.9%

SABS

27.4%

Detailed metrics comparison

IPSC

Century Therapeutics Inc

SABS

SAB Biotherapeutics Inc

Market Cap

IPSC$265M

SABS$228M

Enterprise Value

IPSC$215M

SABS$223M

Price

IPSC$1.47

SABS$2.98

P/E Ratio

IPSCN/A

SABS20.43x

P/S Ratio

IPSC2.41x

SABS204.97x

EV/Sales

IPSC1.98x

SABS201.14x

EV/EBITDA

IPSC0.00x

SABS0.00x

P/B Ratio

IPSC1.19x

SABS1.26x

P/FCF Ratio

IPSCN/A

SABSN/A

EV/FCF

IPSC-2.44x

SABS-3.88x

PEG Ratio

IPSCN/A

SABSN/A

Forward P/E (NTM)

IPSCN/A

SABSN/A

Forward P/S (NTM)

IPSCN/A

SABSN/A

Revenue (TTM)

IPSC$0

SABS$0

Revenue Growth (YoY)

IPSC-100.0%

SABSN/A

Forward Rev Growth

IPSC385.7%

SABS13369.8%

Gross Margin (TTM)

IPSC0.0%

SABS0.0%

Operating Margin (TTM)

IPSC0.0%

SABS0.0%

EBITDA Margin (TTM)

IPSC0.0%

SABS0.0%

Net Margin (TTM)

IPSC0.0%

SABS0.0%

FCF Margin (TTM)

IPSCN/A

SABSN/A

Net Income (TTM)

IPSC$-110M

SABS$2M

FCF (TTM)

IPSC$-88M

SABS$-57M

EPS (TTM)

IPSC-$0.53

SABS$0.00

ROE (TTM)

IPSC-5276.0%

SABS15.2%

ROA (TTM)

IPSC-4059.0%

SABS12.5%

ROIC (TTM)

IPSC-5276.0%

SABS14.6%

Cash

IPSC$50M

SABS$8M

Debt

IPSC$0

SABS$3M

Net Cash/Debt

IPSC$50M

SABS$5M

Current Ratio (TTM)

IPSC8.28x

SABS9.22x

Quick Ratio (TTM)

IPSC7.94x

SABS8.93x

Debt/Equity (TTM)

IPSC0.00x

SABS0.01x

Debt/Assets (TTM)

IPSC0.0%

SABS0.0%

Interest Coverage (TTM)

IPSCN/A

SABSN/A

Net Debt/EBITDA (TTM)

IPSC0.00x

SABS0.00x

Beta

IPSC1.74

SABS0.80

52W Performance

IPSC151.9%

SABS27.4%

YTD Performance

IPSC47.8%

SABS-21.0%

% from 52W High

IPSC-51.6%

SABS-42.1%

% from 52W Low

IPSC237.9%

SABS41.9%

Asset Turnover (TTM)

IPSC0.31x

SABS0.02x

FCF Yield (TTM)

IPSC-33.3%

SABS-25.2%

Earnings Yield (TTM)

IPSC-41.4%

SABS1.1%

Dividend Yield (TTM)

IPSCN/A

SABSN/A

Rule of 40

IPSC-100.0

SABS0.0

EV/GP/RG

IPSCN/A

SABSN/A

Ticker research

View IPSC research View SABS research

Metric	IPSC Century Therapeutics Inc	SABS SAB Biotherapeutics Inc
Market & Valuation
Market Cap	$265M	$228M
Enterprise Value	$215M	$223M
Price	$1.47	$2.98
P/E Ratio	N/A	20.43x
P/S Ratio	2.41x	204.97x
EV/Sales	1.98x	201.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	385.7%	13369.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-110M	$2M
FCF (TTM)	$-88M	$-57M
EPS (TTM)	-$0.53	$0.00
ROE (TTM)	-5276.0%	15.2%
ROA (TTM)	-4059.0%	12.5%
ROIC (TTM)	-5276.0%	14.6%
Financial Health
Cash	$50M	$8M
Debt	$0	$3M
Net Cash/Debt	$50M	$5M
Current Ratio (TTM)	8.28x	9.22x
Quick Ratio (TTM)	7.94x	8.93x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	0.80
52W Performance	151.9%	27.4%
YTD Performance	47.8%	-21.0%
% from 52W High	-51.6%	-42.1%
% from 52W Low	237.9%	41.9%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.02x
FCF Yield (TTM)	-33.3%	-25.2%
Earnings Yield (TTM)	-41.4%	1.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View SABS research